Board of directors

Eric Aguiar , , M.D. ,

Eric Aguiar, M.D. has been a member of our board of directors since September 2010. He has been a partner at the life science investment firm Aisling Capital since January 2016. Prior to joining that firm, he was a partner in the venture capital firm Thomas, McNerney & Partners since 2007. Dr. Aguiar was a Managing Director of HealthCare Ventures, a healthcare focused venture capital firm, from 2001 to 2007. He was Chief Executive Officer and a director of Genovo, Inc., a biopharmaceuticals company focused on gene delivery and gene regulation, from 1998 to 2000. Dr. Aguiar previously served as a director of Amarin Pharmaceuticals, a publicly held biopharmaceutical company, as well as on the boards of numerous private companies including companies in the life sciences industry. He is a member of the Board of Overseers of the Tufts School of Medicine and a member of the Council on Foreign Relations. He received an M.D. with honors from Harvard Medical School and a B.A. in Arts and Sciences from Cornell University. Dr. Aguiar was also a Luce Fellow and is a Chartered Financial Analyst. We believe that Dr. Aguiar is qualified to serve on our board of directors due to his extensive experience in the life science field, his experience on various boards, and his management and financial experience with life sciences companies.

Geoffrey S. Crouse , ,

Geoffrey S. Crouse has served on our board of directors since March 2012. Mr. Crouse served as Chief Executive Officer of Cord Blood Registry (CBR) from September 2012 to August 2015 when the Company was sold to AMAG Pharmaceuticals. He served as Executive Vice President at AMAG until December 2015. CBR stores stem cells from umbilical cord blood and tissue. He previously served as Chief Operating Officer at Immucor, Inc., a publicly traded in vitro diagnostics company, from August 2009 to April 2011. From April 2011 through September 2012, Mr. Crouse was a consultant. Prior to Immucor, he served as Vice President of the life sciences business at Millipore Corporation, a publicly traded provider of technologies, tools, and services for the life science industry, from 2006 to 2009. Prior to joining Millipore, he worked at Roche, a pharmaceuticals and diagnostics company, where he held various roles from 2003 to 2006. Mr. Crouse holds a B.A. in English and Japanese from Boston College and an MBA and Master’s of Public Health from the University of California Berkeley. We believe that Mr. Crouse is qualified to serve on our board of directors due to his extensive experience in the life sciences industry and his management and financial experience with life sciences companies.

Sean George , , Ph.D. ,

Sean is chief executive officer of Invitae, whose mission is to bring genetic information into mainstream medicine. Prior to his CEO position, he served as Invitae’s president and chief operating officer. Sean was a co-founder and CEO of Locus Development, an early stage genetic analysis startup that later merged with Invitae. Prior to co-founding Locus, he served as COO at Navigenics, an early leader in personalized medicine. Previously, he has also served as SVP of Marketing and SVP, Life Science Business at Affymetrix as well as VP, Labeling and Detection Business at Invitrogen. In the past, he has also worked at McKinsey & Co. and Molecular Probes. Dr. George holds a B.S. in Molecular Genetics from UCLA, an M.S. in Molecular Biology from UC Santa Barbara, and a Ph.D. in Molecular Genetics from UC Santa Cruz.

Christine M. Gorjanc , ,

Christine Gorjanc has been on our board of directors and the chair of the Audit Committee since November 2015. Ms. Gorjanc has served as the Chief Financial Officer of NETGEAR, Inc., a provider of networking products and services, since January 2008, where she previously served as Chief Accounting Officer from December 2006 to January 2008 and Vice President, Finance from November 2005 to December 2006. Prior to joining NETGEAR, Inc., Ms. Gorjanc served as Vice President, Controller, Treasurer, and Assistant Secretary for Aspect Communications Corporation, a provider of workforce and customer management solutions, from September 1996 through November 2005. Ms. Gorjanc served as the Manager of Tax for Tandem Computers, Inc., a provider of fault-tolerant computer systems, from October 1988 through September 1996. Prior to that, Ms. Gorjanc served in management positions at Xidex Corporation, a manufacturer of storage devices, and spent eight years in public accounting with a number of accounting firms.
Ms. Gorjanc holds a B.A. in Accounting (with honors) from the University of Texas at El Paso and an M.S. in Taxation from Golden Gate University. Ms. Gorjanc's experience as an executive and financial expert with a rapidly growing international technology company operating in highly competitive markets make her well qualified to lead our Audit Committee.

Kimber Lockhart , ,

Kimber Lockhart is an experienced technology leader, scaling technology platforms to support rapid business growth. Since 2015, Lockhart has served as Chief Technology Officer at One Medical, a national leader in technology-enabled primary care, where she was previously Vice President of Engineering from 2014 to 2015. Prior to joining One Medical, Lockhart served in various engineering leadership roles at Box from 2009 to 2014. Previously, Lockhart was co-founder and CEO of Increo Solutions, provider of document rendering and collaboration technologies, which was acquired by Box in 2009. She holds a B.S. in Computer Science from Stanford University.

Jason Myers , , Ph.D. ,

Jason co-founded and served as President and Chief Executive Officer of ArcherDX, which was acquired by Invitae in 2020. With more than 20 years of experience in the biotech industry, Jason has established a track record of successful technology development and enterprise value creation. Prior to founding Archer, Jason led cross-functional platform and sequencing application development for Ion TorrentTM, which was acquired by Life Technologies in 2010. In addition, Jason discovered and successfully licensed a first of its kind loss-of-function RNAI screening product to several leading life science tools companies. Jason received his Ph.D. in Molecular Pharmacology from Stanford University School of Medicine and a Bachelor of Science from Colorado State University.

Chitra Nayak , ,

Chitra Nayak has more than 25 years of professional experience in product management, sales leadership, general management and operations roles at various companies, having successfully built operational engines to enable these businesses to scale. Most recently she was COO running GTM at Comfy, Inc., a disruptive real-estate tech startup revolutionizing the way people interact with their workplaces. Prior to joining Comfy in 2017, Nayak served as chief operating officer of Funding Circle LTD from 2015 to 2016. From 2007 to 2015, Nayak served in several positions at, Inc., including vice president of marketing strategy and operations from 2007 to 2008, senior vice president of global sales development from 2008 to 2013, and chief operating officer of platform from 2013 to 2015. Nayak holds an M.B.A in Business Administration from Harvard Business School, an M.S. in Environmental Engineering from Cornell University, and a B.S. in engineering from Indian Institute of Technology.

Investor Toolkit

Feature Presentation

Email Alerts

Sign up to receive Invitae financial information by email.
Email Address: *

Enter the code shown above.

Investor Contact

1400 16th St.
San Francisco, CA, 94103